TY  - JOUR
AU  - Hemminki, Kari
AU  - Sundquist, Kristina
AU  - Sundquist, Jan
AU  - Försti, Asta
AU  - Liska, Vaclav
AU  - Hemminki, Akseli
AU  - Li, Xinjun
TI  - Autoimmune diseases as comorbidities for liver, gallbladder, and biliary duct cancers in Sweden.
JO  - Cancer
VL  - 129
IS  - 8
SN  - 0008-543x
CY  - New York, NY
PB  - Wiley-Liss
M1  - DKFZ-2023-00228
SP  - 1227-1236
PY  - 2023
N1  - #EA:C020# / Volume129, Issue 8, 15 April 2023, Pages 1227-1236
AB  - Autoimmune diseases are associated with many cancers but there is a lack of population-based studies with different autoimmune diseases that have a long follow-up. This is also true of hepatobiliary cancers, which include hepatocellular cancer (HCC) and rarer entities of gallbladder cancer (GBC), intra- and extrahepatic cholangiocarcinoma (iCCA and eCCA), and ampullary cancer.Diagnostic data on 43 autoimmune diseases were collected from the Swedish Inpatient Register from 1987 to 2018, and cancer data were derived from the national cancer registry from 1997 onward. Relative risks were expressed as standardized incidence ratios (SIRs).In a population of 13.6 million, 1.1 million autoimmune diseases were diagnosed and subsequent hepatobiliary cancer was diagnosed in 3191 patients (17.2
KW  - comorbidity (Other)
KW  - discharge data (Other)
KW  - hepatocellular cancer (Other)
KW  - immune disturbance (Other)
KW  - risk factor (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:36715017
DO  - DOI:10.1002/cncr.34663
UR  - https://inrepo02.dkfz.de/record/212543
ER  -